ARTA
AVNR

A.R.T. Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

A.R.T. Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-320,268
Closed -$3.82M – 1892
2014
Q3 		$3.82M Buy
+320,268
New +$2.19M 0.18% 151
2014
Q2 		– Sell
-104,616
Closed -$383K – 1750
2014
Q1 		$383K Buy
+104,616
New +$399K 0.02% 880
2013
Q3 		– Sell
-107,698
Closed -$495K – 1701
2013
Q2 		$495K Buy
+107,698
New +$370K 0.02% 879

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

A.R.T. Advisors's AVNR Position: Q4 2014 in Review

A.R.T. Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 320,268 shares — an estimated $3.82M sold.

A.R.T. Advisors first reported a position in AVNR in Q2 2013 and held it in 3 quarters. The position peaked at $3.82M in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • A.R.T. Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • A.R.T. Advisors sold 320,268 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $3.82M.
  • A.R.T. Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 3 quarters.
  • A.R.T. Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $3.82M in Q3 2014.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on A.R.T. Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.